{"transactions":[{"id":2081597,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-19T07:09:44.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":30000,"price":1.1,"value":33000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.11. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected."}],"balance_after":46337,"source":{"system":"sec-edgar","filing":"0001415889-22-012652","document":"form4-12192022_121236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922012652/form4-12192022_121236.xml","form_type":"4"}},{"id":2081413,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-19T07:08:15.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":7021,"price":1.11,"value":7793.31,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total number of shares held is reduced by 40 shares to correct an arithmetic error in the original Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The form of ownership has been changed from Indirect to Direct.  The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error."}],"balance_after":16337,"source":{"system":"sec-edgar","filing":"0001415889-22-012650","document":"form4a-12192022_121206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922012650/form4a-12192022_121206.xml","form_type":"4/A","original_submission_date":"2022-11-28"}},{"id":2081412,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-19T07:08:15.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":600,"price":1.1,"value":660.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error."}],"balance_after":9316,"source":{"system":"sec-edgar","filing":"0001415889-22-012650","document":"form4a-12192022_121206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922012650/form4a-12192022_121206.xml","form_type":"4/A","original_submission_date":"2022-11-28"}},{"id":2081411,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-19T07:08:15.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":8716,"price":1.12,"value":9761.92,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error."}],"balance_after":8716,"source":{"system":"sec-edgar","filing":"0001415889-22-012650","document":"form4a-12192022_121206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922012650/form4a-12192022_121206.xml","form_type":"4/A","original_submission_date":"2022-11-28"}},{"id":2103276,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-11-28T07:42:26.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":7021,"price":1.11,"value":7793.31,"ownership":{"direct":false,"nature":"Shares purchased though 401(k) plan"},"balance_after":16377,"source":{"system":"sec-edgar","filing":"0001415889-22-011778","document":"form4-11282022_121119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922011778/form4-11282022_121119.xml","form_type":"4"}},{"id":2103275,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-11-28T07:42:26.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":600,"price":1.1,"value":660.0,"ownership":{"direct":false,"nature":"Shares purchased though 401(k) plan"},"balance_after":9316,"source":{"system":"sec-edgar","filing":"0001415889-22-011778","document":"form4-11282022_121119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922011778/form4-11282022_121119.xml","form_type":"4"}},{"id":2103274,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-11-28T07:42:26.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":8716,"price":1.12,"value":9761.92,"ownership":{"direct":false,"nature":"Shares purchased though 401(k) plan"},"balance_after":8716,"source":{"system":"sec-edgar","filing":"0001415889-22-011778","document":"form4-11282022_121119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1284934/000141588922011778/form4-11282022_121119.xml","form_type":"4"}},{"id":2663662,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-17T22:52:14.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":17647,"price":8.5,"value":149999.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021."}],"balance_after":17647,"source":{"system":"sec-edgar","filing":"0001140361-21-021491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021491/form4.xml","form_type":"4"}},{"id":2915432,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T21:06:01.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":202800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended.  The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 1, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":202800,"derivative":{"exercise_price":2.28,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":202800},"source":{"system":"sec-edgar","filing":"0001140361-21-000334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121000334/form4.xml","form_type":"4"}},{"id":3254828,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents payment of $257,641 aggregate exercise price of these options by the reduction of securities issued by 63,537 shares, resulting in a net issuance of 91,554 shares."}],"balance_after":150100,"derivative":{"exercise_price":3.11,"exercise_date":"2019-12-31","expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254827,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents payment of $257,641 aggregate exercise price of these options by the reduction of securities issued by 63,537 shares, resulting in a net issuance of 91,554 shares."}],"balance_after":170100,"derivative":{"exercise_price":2.89,"exercise_date":"2019-06-13","expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254826,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":60091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents payment of $257,641 aggregate exercise price of these options by the reduction of securities issued by 63,537 shares, resulting in a net issuance of 91,554 shares."}],"balance_after":190100,"derivative":{"exercise_price":1,"exercise_date":"2018-04-19","expiration_date":"2028-04-18","underlying":"Common Stock","underlying_shares":60091},"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254825,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents payment of $257,641 aggregate exercise price of these options by the reduction of securities issued by 63,537 shares, resulting in a net issuance of 91,554 shares."}],"balance_after":250191,"derivative":{"exercise_price":1.06,"exercise_date":"2017-12-31","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254824,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents payment of $257,641 aggregate exercise price of these options by the reduction of securities issued by 63,537 shares, resulting in a net issuance of 91,554 shares."}],"balance_after":280191,"derivative":{"exercise_price":1.83,"exercise_date":"2016-12-31","expiration_date":"2026-12-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254823,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Common Stock","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"tax_withholding","acquired":true,"shares":4661,"price":3.11,"value":14495.71,"ownership":{"direct":true},"balance_after":230454,"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254822,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Common Stock","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"tax_withholding","acquired":true,"shares":5746,"price":2.89,"value":16605.94,"ownership":{"direct":true},"balance_after":225793,"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254821,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Common Stock","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"tax_withholding","acquired":true,"shares":45272,"price":1,"value":45272.0,"ownership":{"direct":true},"balance_after":220047,"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254820,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Common Stock","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"tax_withholding","acquired":true,"shares":22158,"price":1.06,"value":23487.48,"ownership":{"direct":true},"balance_after":174775,"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3254819,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Common Stock","published_at":"2020-02-24T21:30:34.000Z","date":"2020-02-21","kind":"tax_withholding","acquired":true,"shares":13717,"price":1.83,"value":25102.11,"ownership":{"direct":true},"balance_after":152617,"source":{"system":"sec-edgar","filing":"0001493152-20-002886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220002886/ownership.xml","form_type":"4"}},{"id":3328231,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option(right to buy)","published_at":"2020-01-02T21:00:39.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":305191,"derivative":{"exercise_price":3.11,"exercise_date":"2019-12-31","expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315220000036/form4.xml","form_type":"4"}},{"id":3488780,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option(right to buy)","published_at":"2019-06-17T13:00:25.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":285191,"derivative":{"exercise_price":2.89,"exercise_date":"2019-06-13","expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-19-009286","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315219009286/form4.xml","form_type":"4"}},{"id":3946275,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option(right to buy)","published_at":"2018-05-04T20:05:22.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":60091,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":265191,"derivative":{"exercise_price":1,"exercise_date":"2018-05-03","expiration_date":"2028-04-18","underlying":"Common Stock","underlying_shares":60091},"source":{"system":"sec-edgar","filing":"0001493152-18-006262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315218006262/form4.xml","form_type":"4"}},{"id":4115164,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option(right to buy)","published_at":"2018-01-03T21:30:38.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":205100,"derivative":{"exercise_price":1.06,"exercise_date":"2017-12-31","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-18-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315218000098/form4.xml","form_type":"4"}},{"id":4211005,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Buisness Develpoment"}}],"security":"Common Stock","published_at":"2017-09-13T12:30:24.000Z","date":"2017-09-12","kind":"purchase","acquired":true,"shares":4000,"price":1.15,"value":4600.0,"ownership":{"direct":true},"balance_after":138900,"source":{"system":"sec-edgar","filing":"0001493152-17-010518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315217010518/form4.xml","form_type":"4"}},{"id":4509160,"issuer":{"id":7794,"kind":"organization","name":"RESEARCH FRONTIERS INC"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & VP-Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-03T21:25:58.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":175100,"derivative":{"exercise_price":1.83,"exercise_date":"2016-12-31","expiration_date":"2026-12-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-17-000050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/793524/000149315217000050/form4.xml","form_type":"4"}}]}